Stock Price
4.97
Daily Change
-0.80%
Yearly
-34.00%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abbott 130.27 1.89 1.47% 20.73%
Accelerate Diagnostics 4.97 -0.04 -0.80% -34.00%
Becton, Dickinson and Co. 244.12 2.18 0.90% 0.56%
Bio-Rad Laboratories 741.38 -6.84 -0.91% 32.53%
Bruker 79.04 -2.28 -2.80% 47.30%
Danaher 312.94 -3.12 -0.99% 39.44%
Exact Sciences 76.59 -3.98 -4.94% -42.36%
GenMark Diagnostics 24.04 0 0% 169.66%
Hologic 73.94 0.17 0.23% 1.07%
Illumina 347.28 -10.20 -2.85% -0.96%
Luminex 36.99 0 0% 10.02%
Myriad Genetics 24.38 -1.15 -4.50% 29.13%
NanoString Technologies 37.35 -1.42 -3.66% -36.51%
Oxford Immunotec Global 21.95 -0.04 -0.18% 80.07%
Pacific Biosciences Of California 20.47 -1.09 -5.06% 1.44%
PerkinElmer 183.17 3.18 1.77% 29.19%
Quidel 147.95 1.45 0.99% -23.57%
Thermo Fisher Scientific 636.11 8.53 1.36% 34.03%
Meridian Bioscience 19.60 -0.16 -0.81% 7.99%

Indexes Price Day Year
NASDAQ 15085 -295.85 -1.92% 21.03%
US2000 2159 -47.02 -2.13% 14.10%

Accelerate Diagnostics
Accelerate Diagnostics, Inc. is an vitro diagnostics company engaged in providing solutions that improve patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. It detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results. The Accelerate Pheno system features walk-away automation and consists of a fixed instrument and single-use test kit. The Accelerate PhenoTest BC Kit provides ID and AST results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk.